Completed NCT00699218
This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 65 Years
Countries United States
Sponsor University of California, Davis
Condition Bipolarity, Depression Completed NCT02476877
This study exists to learn from real-world information that can show how a digital app or remote support tool fits into care. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.
Remote / online Why is this study shown? This study includes Bipolarity among several conditions.
Schizophrenia, Bipolarity, ... Other Over 18 Years
Countries United States
Sponsor Advanced Clinical Laboratory Solutions, Inc.
Condition Schizophrenia, Bipolarity, ... Completed NCT00363337
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug i A study involving a medication or substance. Over 18 Years
Countries United States
Sponsor Lindner Center of HOPE
Condition Bipolarity, Depression Completed NCT00844857
This summary needs review. Please check the official study record and contact the research team for details.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug From 10 Years to 17 Years
Countries United States, Russia
Sponsor Eli Lilly and Company
Condition Bipolarity, Depression Completed NCT00094432
This study is completed in the United States. It is testing aripiprazole for depression.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug From 18 Years to 65 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Bipolarity, Depression Completed NCT05328297
This study is completed in the United States, in Canada, in Poland, .... It is testing JNJ-55308942 for depression in bipolarity.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug From 18 Years to 64 Years
Countries United States, Canada, Poland, ...
Sponsor Janssen Pharmaceutica N.V., Belgium
Condition Bipolarity, Depression Terminated NCT00939887
This study was terminated in the United States. It focuses on Bipolarity.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Depression Drug From 18 Years to 55 Years
Countries United States
Sponsor Pfizer
Condition Bipolarity, Depression Completed NCT03615794
This study is completed in the United States. It focuses on Depression.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Bipolarity, ... Other From 18 Years to 50 Years
Countries United States
Sponsor Johns Hopkins University
Condition Depression, Bipolarity, ... Completed NCT07549581
This study is completed in the United States. It is testing SEP-380135 for depression.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Depression, Schizophrenia, ... Drug From 18 Years to 55 Years
Countries United States
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Depression, Schizophrenia, ... Completed NCT00650611
This study is completed in the United States. It is testing ziprasidone for Schizophrenia.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Schizophrenia, Bipolarity Drug From 10 Years to 17 Years
Countries United States
Sponsor Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition Schizophrenia, Bipolarity Completed NCT00621777
This study is completed in the United States. It is testing varenicline for schizophrenia.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Schizophrenia Drug From 18 Years to 70 Years
Countries United States
Sponsor Massachusetts General Hospital
Condition Bipolarity, Schizophrenia Completed NCT06024239
This study is completed in the United States. It is testing Pharmacokinetics, Safety, and Tolerability of ABBV-932 for anxiety.
In United States Why is this study shown? This study includes Bipolarity among several conditions.
Bipolarity, Anxiety Drug From 18 Years to 65 Years
Countries United States
Sponsor AbbVie
Condition Bipolarity, Anxiety 
